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1. Introduction 
The mechanism responsible for initiating and controlling burn-induced immunosuppression 
remains unknown. Accumulating experimental and clinical data indicates that burn injury 
promotes suppressed immune function, predisposing the host to infectious complications 
(Moss NM, 1988).  Skin plays an indispensable first line of defense against microorganisms; 
the disruption of this primary barrier in burn injury leaves patients greatly susceptible to 
invasion by pathogens and increases their morbidity and mortality.  Severely burn-injured 
patients exhibit classical signs of suppressed immune function such as loss of delayed-type 
hypersensitivity responses, prolonged skin allograft survival and reduced T-cell 
proliferation to polyclonal and antigen-specific stimulation (Ninnemann JL, 1994, Lederer, 
JA, 1999, Faist E, 1996). The disturbances in T-cell mediated responses include low T-helper 
1 (Th-1) type cytokine production and reduced Th-1 type antibody isotype secretion (Kelly, 
JL, 1999). There is a rising incidence of nosocomial infections accompanied by burn-induced 
adaptive immunosuppression (Baker, CC, 1979, Angele MK, 2002). This shift of adaptive 
immune response towards a counter-inflammatory phenotype takes place in the presence of 
proinflammatory innate immune response (Harris, BH, 1995). An estimated 40, 000 adults 
are admitted to hospitals in USA with burns each year (Salinas J et al, 2008, White CE, 2008). 
Severe burn-injury stimulates a massive release of cytokines into the bloodstream leading to 
shock, immune dysfunction, and multiorgan failure. Serum levels of interleukin (IL)-8, 
tumor necrosis factor-┙, IL-6, and granulocyte-macrophage colony stimulatory factor (GM-
CSF) peak within first week postburn. In addition to shock, this rush of cytokines triggers a 
hypercatabolic state, with muscle wasting and immunosuppression. Eventually, this 
immunosuppression follows multiorgan dysfunction, sepsis and heralds death.  
2. SIRS-CARS (Figures 1-5) 
This paradigm is currently accepted by the investigators in the field of burn, shock and 
trauma. Extensive tissue destruction following burn-injury predisposes patients to 
consequences of different and dysregulated inflammatory immune responses (Saffle, JR, 
1993, Baue, AE, 1998, Still, JM, 1993). Following the initial resuscitation period, patients 
develop systemic inflammatory response syndrome (SIRS), which leads to multiple organ 
dysfunction syndrome (MODS) which is associated with high mortality. If the patients do 
not develop early MODS and survive SIRS they characterize suppressed immunity and 
resistance to infection, which is termed as compensatory anti-inflammatory response 
syndrome (CARS). Baue et al, 1998 supports the theory that interactions between the innate  
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Fig. 1. A schematic drawing of mediators released during different phases of immune 
response following burn injury. X-axis show levels of mediators released against time (y-
axis) following monocyte/macrophages activation. Mediators released during the early pro-
inflammatory phase (Systemic inflammatory response syndrome (SIRS) are TNF┙, IL-1, IL-6, 
IL-8  and IL-12 followed by anti-inflammatory phase where IL-10, IL-1RA, TGF┚, IL-13, 
PGE2 are released. Mixed antagonistic response syndrome (MARS) with both pro-and anti-
inflammatory components has not been in literature since year 2000. At the meantime a 
refractory state is also initiated which continues even after compensatory anti-inflammatory 
response syndrome (CARS) is over. 
 
 
Fig. 2. Systemic inflammatory response syndrome (SIRS) leading to release of pro-
inflammatory mediators; leading to cell/tissue damage; leading to multiple organ failure; 
leading to death. 
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Fig. 3. A schematic drawing of cascade of events (first scenario) where both pro-
inflammatory as well as anti-inflammatory immune responses are initiated, eventually 
leading to mortality. In this scenario anti-inflammatory mediators cause dysfunction of cell-
mediated immunity (CMI) leading to death via immunosuppression. 
 
 
Fig. 4. A schematic drawing of cascade of events (second scenario) when SIRS is complicated 
by overwhelming infections following dysregulated cell-mediated immunity, leading to 
mortality. In this case dysfunction of cell-mediated immunity leads a way to overwhelming 
infections and then classical pathway of cell and tissue damage responsible for multiple 
organ failure (MOF) paves the way to mortality. 
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Fig. 5. A schematic outcome of compensatory anti-inflammatory response syndrome (CARS) 
in a beneficial outcome of recovery leading to survival (third scenario). In this alternative 
sequence of events anti-inflammatory mediators set the stage up for a compensatory anti-
inflammatory response syndrome (CARS) which down regulates cell and tissue damage and 
halts multiple organ failure thus positively influence the outcome of (SIRS) towards a 
recovery phase. 
and adaptive immune systems are important in the induction of CARS and SIRS. Burn-
induced immune dysregulation is a continuously changing process and evolves over time 
and goes into a refractory state.  
3. Locally released inflammatory mediators (Figure 6-7) 
Pro-inflammatory cascade of cytokine released immediately after injury is a harbinger of 
subsequent immune dysfunction, sepsis and multiple organ failure (Meakins, JL, 1990). The 
cells of innate immune system including macrophages, fibroblasts, natural killer (NK) cells, 
activated T-cells release pro-inflammatory cytokines i.e., interleukin-1 (IL-1), tumor necrosis 
factor–┙ (TNF-┙), IL-6, transforming growth factor–┚ (TGF-┚), reactive nitrogen 
intermediates (RNI), prostaglandin E2 (PGE2) (Ogle, CK, 1994). These cytokines and other 
mediators are triggered by both non-infectious and infectious stimuli (Figures 6 and 7). The 
inflammatory SIRS response is known to be caused by stimuli other than sepsis in contrast 
to CARS that follows invasive infection. Marano MA, 1990 and Gamelli RL, 1995 
documented increased systemic levels of these inflammatory mediators following burn 
injury altering the functional capacity of their parent cells. This elevated production of 
inflammatory mediators has thus been implicated for post-burn sepsis (Schwacha MG, 1998, 
Yang L, 1992, O’Riordain, MG, 1992). Locally released inflammatory mediators, i.e, C3a, 
C5a, PG, LT, O2-, NO, TNF┙, IL1, IL6, IL8, IL10, TGF┚ act on different circulating cells 
(leukocytes/platelets) and other tissues (endothelium, epithelium and parenchymal cells) 
and neuro-endocrine axis to enhance different effector responses. 
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Fig. 6. Locally released inflammatory mediators triggered by both non-infectious vs. 
infectious stimuli. A list of humoral and cell-derived factors is given which will determine 
the potential outcome of burn-injury associated tissue damage. In the first sequence of 
events non-infectious stimuli cause hypoxia/ischemia type of injury and release of tissue 
breakdown products, mostly initiating a humoral response and a list of modulators causing 
inflammation. In the event of infectious stimuli LPS, Peptidoglycan activate predominantly 
a cellular immune response, again triggering release of a list of cytokines and chemokines. 
These include but do not limit to release of platelet-activating factor (PAF), prostaglandin 
(PG), lymphotoxin (LT), reactive oxygen species (ROS), reactive nitrogen species (RNI), 
monocyte chemotactic protein-1 (MCP-1), and macrophage inflammatory protein-1 (MIP-1). 
 
 
Fig. 7. Locally released inflammatory mediators act on different circulating cells 
(leukocytes/platelets) and other tissues (endothelium, epithelium and parenchymal cells) 
and neuro-endocrine axis to enhance different effector responses. Leucocytes and platelets 
are activated and are recruited to the site of injury. Microvascular changes are brought about 
by both humoral and cell-mediated factors acting on endothelium, epithelium and 
parencyhmal cells, and finally, via neuroendocrine axis stress hormones (i.e, cortisol) are 
released which affect metabolism. 
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4. Systemically released mediators (Figure 8) 
Endogenous mediators related to burn injury include a list, i.e., C-reactive proteins, serum 
amyloid A, procalcitonin, C3 complement and haptaglobin, etc. These circulating mediators 
influence endothelial, epithelial and other types of cells. These inflammatory mediators act 
as double-edged swords (Figure 8).  
 
 
Fig. 8. Inflammatory mediators act like double-edged swords. Cascade of events could either 
lead to recovery or causing cell tissue damage and/or immunosuppression culminating in 
multiple organ failure and shock. Pro-inflammatory mediators help in host defense and 
positively influence cell proliferation/growth and enhance tissue repair-all processes leading 
to recovery, whereas anti-inflammatory mediators assist in controlling inflammation and limit 
catabolism thus helping recovery. On the flipside, pro-inflammatory mediators may also 
culminate in cell/tissue damage, cardiovascular/respiratory failure, and likewise anti-
inflammatory mediators decrease host defense via initiating immunosuppression. Thus it acts 
like a double-edged sword- complementing further multiple organ failure and shock. 
5. Pro-inflammatory and anti-inflammatory immune responses (Figures 9-16) 
In the midst of burn-injury immune responses pro-inflammatory and anti-inflammatory 
immune responses elicit different responses. The most notable of pro-inflammatory 
responses include leukocytosis, enhanced adherence, fever, hypermetablism, activation of 
HPA axis and acute phase protein response in the liver. Anti-inflammatory immune 
responses serve to deactivate leukocyte activation, myelosuppression, abrogate 
hypermetabolism, and suppress tissue repair and most importantly immunosuppression of 
cell-mediated adaptive immunity. Figures 9-16 explain the dual hit immune response and 
the details of burn-induced cascade of effector responses leading to infection, sepsis and 
later complications. 
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Fig. 9. Timeline of release of pro-inflammatory cytokine cascade in term of hours following 
their release from activated monocytes and/or macrophages. The first cytokine to appear 
and peak within hours is TNF┙. IL-1 and IL-6 are also initiated but peak when TNF┙ levels 
begin to fall down. IL-1 peaks at higher levels than IL-6 and finally IL-8 is among the last to 
appear in this sequence of cascade of inflammatory cytokines. 
 
 
Fig. 10. Pro- and/or anti-inflammatory immune responses are initiated by the respective 
pro- or anti-inflammatory cytokines leading to two different outcomes as given in this figure. 
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Fig. 11. A two-hit model: Primary hit (burn) when compounded by secondary hit (infection) 
operates through hyperactivation response (monocytes, macrophages and neutrophil)-
mediated or immunosuppression (macrophages, antigen-presenting cells, T cells)-mediated- 
leading to tissue damage and immune dysfunction. This unregulated immune responses 
leads to sepsis syndrome/septic shock and multiple organ failure. 
 
 
Fig. 12. This figure shows the timeline of burn with sepsis immune response. There is early 
neutrophil-mediated exaggerated or excessive immune response followed by T-cell 
mediated immunosuppression. Early PMN-responsible increases adhesion of neutrophils to 
endothelium, increased tissue infiltration, and increased oxygen radical burst. This 
heightened PMN response then causes tissue damage to liver, lungs, and intestine, 
especially compromised intestinal barrier leads to bacterial translocation. A later T cell-
mediated response causing immunosuppression (decreased cell proliferation and cell-
mediated immunity). These early PMN and late T-cell cause multiple organ failure. 
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Fig. 13. Sequence of potential immune-pathologic pathways following burn/infection. 
Organ dysfunction, vital tissue injury and immunosuppression lead to morbidity. Optimal 
host defense, enhanced phagocytosis/infection control and an optimum cellular immunity 
leads to recovery. Three probable cells of innate and adaptive immunity are involved in a 
mixture of positive (recovery) or negative (morbidity) outcome; Firstly, Monocytes and 
macrophages get activated and release pro-inflammatory cytokines, which have a positive 
(optimal host defense)-leading to recovery or negative (organ dysfunction)-leading to 
morbidity. Secondly, PMN release reactive oxygen intermediates (ROI), reactive nitrogen 
intermediates (RNI), proteases which have a positive (phagocytosis of pathogens)-leading to 
recovery or a negative (tissue injury to vital organs)-leading to morbidity. Thirdly, T cell-
mediated events; positive (optimum cellular immunity)-leading to recovery or negative 
(immunosuppression)-leading to morbidity. 
 
 
Fig. 14. A possible scenario when pro-inflammatory immune response is stronger than anti-
inflammatory immune response. 
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Fig. 15. A possible scenario when anti-inflammatory immune response is stronger than pro-
inflammatory immune response. 
 
 
Fig. 16. A flow diagram of immune mechanisms of sepsis involving infectious only, or 
trauma/burn injury, detailing the list of possible immunomodulators that affect the final 
outcome leading to immunosuppression. 
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6. Role of lymphocyte subsets in burn injury and sepsis 
The known roles of lymphocyte subsets i.e., natural killer (NK) cells, natural killer T (NKT), 
gamma-delta (┛δ) T cells, and naturally occurring regulatory T cells (Treg) cells in the 
context of burn and septic injury have recently emerged (Schneider DF, 2007). Jobin et al, 
2000 showed that in serum of human burn patient’s concentration of sIL-2Ra correlated with 
intake of fat in diet and inhibition of in vitro NK-cell activity by recombinant sIL-2Ra. 
Primary mechanisms of NK cell cytotoxicity is known to be via perforin, granzymes, TNF-┙, 
and Fas/FasL. The data obtained from human studies is although inconsistent; and known 
to be modulated by stress hormones, number of circulating NK cells, presence of IL-4 and 
IL-10, catalase enzyme, etc. In sepsis, antigen-presenting cells (APCs; macrophages and 
dendritic cells) recognize antigens or endotoxin and secrete IL-12, which activates NK cells 
to produce copious amounts of IFN-┛ and TNF-┙ (Medzhitov R, 1998). Burn-induced T cell 
immunosuppression in a mouse scald burn model along with delayed-type hypersensitivity 
(DTH) required both CD1d expressing antigen-presenting cells and NK cells (Faunce et al, 
2003, Palmer et al, 2006). The role of gamma-delta (┛δ) in early burn injury has been 
elaborated by Schwacha MG 2003, et al, 2000), and has been found to contribute in wound 
healing, inflammation, and overall survival. However, in other burn studies ┛δ T cells 
contributed to neutrophil-mediated tissue damage of lung and small intestine (Toth B et al, 
2004, Wu X, 2004). Hence beneficial and harmful effects of ┛δ T cells are unclear and 
conflicting, although some researchers have proposed a bimodal response, where they act as 
proinflammatory in early phases of infection and regulatory in the later phases. 
CD4+CD25+ regulatory T cells (Treg), overall anti-inflammatory cells are known to 
comprise 5-12% of CD4+ T cells both in lymphoid and circulatory compartments. In burn 
model Treg were found to decrease inflammatory cytokine release a week after burn and 
infectious challenge (Murphy et al, 2005). In a similar burn model Treg were found to inhibit 
TGF-┚ and CD4+ proliferation in a cell-to-cell contact (Ni Choileain N, et al, 2006). In 
contrast a study of polymicrobial cecal-ligation-puncture (CLP) peritonitis model Tregs 
were found to have protective effects (Heuer JG et al, 2005). The mechanisms by which these 
small lymphocyte subsets regulate or control remains subject of future studies but final 
effector responses are modulated through cascade of cytokines, like IFN-┛, IL-4, IL-6, IL-10 
and TGF-┚.  
7. Role of antigen presenting cells and T cells 
To date, their involvement as critical regulatory molecules responsible for T cell suppression 
in burn and septic injuries continues to be a subject of extensive studies as evident from 
reports from several laboratories (Schneider DF, 2007). Recent studies have provided 
evidence that alterations in costimulatory signaling between APCs (antigen presenting cells) 
and CD4+ T cells play key roles in disturbing T cell activation and effector responses. For 
example, altered expression and functions of costimulatory molecules on APCs, CD80/86, 
CD40, ICOSL, and/or alterations in their interactions with the complementary molecules on 
T cells, CD28, CTLA-4, CD40L, ICOS can adversely affect T cell activation and responses 
(Alegre ML, 2001, Okazaki T., 2002, Grohmann U, 2002). Such derangements in APC and T 
cell interactions may also contribute to burn/sepsis-related down-regulation of CD4+ T 
cells. Of APCs, dendritic cells (DC) are recognized to be unique not only in effectively 
activating naïve T cells but also in adversely affecting their functioning. Recent studies have 
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emphasized the role of induction of indoleamine 2, 3-dioxygenase (IDO) in DCs inhibiting 
growth and survival of T cells interacting with such DCs (Grohmann U, 2002, Uyttenhove, 
C, 2003, Mellor, AL, 2003). A derangement in DCs’ CD40 interaction with T cell CD40L has 
also been implicated in T cell functional inhibition (Bingaman, AW, 2001, Straw, AD, 2003). 
The end effect(s) of alerted co-stimulatory signaling between APCs and CD4+ T cells could 
be derangements in cell signaling pathways leading to anergy, apoptosis and/or a 
regulatory T cell (Treg) mediated suppression of CD4+ T cells (Tang, Q, 2003). Our previous 
studies have assessed individual effects of burn and sepsis as well as of superimposition of 
sepsis on burn in rats on CD4+ T cell dysfunction and intestinal dysfunction, and animal 
mortality (Fazal et al, 2000-2010). While burn or sepsis produced low mortality, the 
combined injury resulted in exacerbation of mortality. The focus in these studies on burn 
and/or sepsis affords us an opportunity to assess potential sub-lethal versus lethal 
implications of combined T cell and APC dysfunction. A lack of functional adaptive and 
innate immunity would lead to high mortality. These studies indicated also that while burn 
or sepsis suppressed IL-2 production/proliferation without a substantial increase in 
apoptosis in MLN CD4+T cells, burn-plus-sepsis caused not only suppressed IL-2 
production/proliferation but also a substantial increase in apoptosis in CD4+T cells. Our 
findings also support potential disturbances in interactions between T cells’ and APCs’ co-
stimulatory receptors/ligands contributing to CD4+T cell deficits in burn and/or sepsis 
injured animals. We hypothesized that CD4+T cell functional inhibition/apoptosis with 
burn and/sepsis injuries resulted from altered co-stimulatory signaling between the T cell 
and APC. Recent studies, while indicating immature DC to adversely affect naive T cells 
have also shown inappropriately activated T cells to adversely affect APCs including DCs 
and macrophages. Both the DC effects on T cells and the T cell effects on APCs are best 
understood to be exerted through altered co-stimulatory signaling between T cells and 
DCs/APCs. These recent findings would seem to support the concept that burn and/or 
sepsis-related T cell dysfunction may also emanate from DCs defectively activating naïve T 
cells, and that functionally incompetent T cells in turn adversely affect tissue DCs and 
macrophages. Such interdependent disturbances in T cell and DC/APC functions can 
contribute to not only impaired cell mediated immunity but also concurrent increased risk 
of bacterial infections, and thereby further increase risks for morbidity and mortality in burn 
and/or sepsis injured hosts.  
8. Immune deficits after thermal injury and septic complications 
A number of laboratory and clinical studies have shown that extensive thermal injury 
induces a state of immune-insufficiency, and that the immune-refractoriness predisposes the 
injured host to critical morbidity and mortality (Toliver-Kinsky, TE, 2002, Kobayashi, M. 
2002). The principal outcome of such immune-insufficiency is an increased susceptibility of 
injured host to opportunistic pathogens causing high risk of death. Both clinical and 
laboratory studies have shown that immune-insufficiency with burns is characterized by 
monocyte/macrophage hypoactivity and/or depressed adaptive cell-mediated immunity 
associated with T lymphocyte functional deficits (Ravindranath, T, 2001). Despite rather 
extensive studies of T cell functional deficits in animal models of burn injury and in patients 
(Barret, JP, 2003); the mechanisms of such deficits and a potential role of these deficits in the 
lethal outcome following burns particularly with the septic complications have remained 
unknown.  
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9. Gastrointestinal mucosal immune defense in burn/septic injuries (Figures 
17-18) 
The intestinal mucosal compartment is presumably the most active regional lymphocyte 
defense system in the body. It serves as an important first line of defense against 
pathogenic/non-pathogenic antigens such as those found in ingested food and those 
derived from the commensal gut bacteria. An early pathophysiologic event following burn 
as well as sepsis injury, of certain critical magnitude, is a disturbance in intestinal 
microvascular dynamics which adversely affects the mucosal barrier integrity. Such a loss of 
barrier integrity has a high probability of grossly increasing the antigen load particularly 
that derived from the commensal bacteria and potentially aggravating the mucosal 
lymphocyte defense. There is also the likelihood that the resulting inadequacy of the 
lymphocytes could exacerbate pathogenic injury to host tissues and organs exacerbating 
host morbidity and mortality. Thus, by virtue of their location, intestine associated 
lymphocytes constitute a vulnerable immune defense system, which could be investigated 
to elucidate the mechanism(s) of immune dysfunction contributing to host morbidity and 
mortality after burn-plus-sepsis. T lymphocytes are found in the GI tract in the mucosal 
epithelial layer (intraepithelial T cells), Peyer’s patches, and lamina propria. While the 
intraepithelial T cells are primarily CD8+ cells, the majority of T cells in the lamina propria 
are CD4+ cells. Peyer’s patches contain predominantly B cells and a relatively small 
population of CD4+ T cells; their lymphoid follicles resemble those in spleens and other 
lymph nodes. The CD4+T cells in lamina propria are the activated (CD45RClow) cells, and 
have been shown to be derived from the mesenteric lymph nodes (MLN) (Ramirez, F, 2000,  
 
 
Fig. 17. Pathophysiological gastrointestinal modulations following injury caused by 
Trauma/Burn/Ischemia/Infection. There are changes in splanchnic blood vessels and 
mucosal beds mimicking ischemia/reperfusion injury. This leads to chemotaxis of activated 
neutrophils, increased vascular and mucosal permeability. These vascular and mucosal 
barrier interruptions cause nutrient transport failure and translocation of bacteria across the 
gut barrier. 
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Fig. 18. Gastrointestinal modulations following exclusive burn injury and/or 
burn/infection. There are changes in splanchnic blood vessels and mucosal beds mimicking 
ischemia/reperfusion injury. This leads to chemotaxis of activated neutrophils, increased 
vascular and mucosal permeability. These vascular and mucosal barrier interruptions cause 
nutrient transport failure and translocation of bacteria across the gut barrier. 
Bode U, 2002). The CD4+T cells probably recognized and activated by the antigens 
presenting cells (APCs) in the MLN (Homann, D, 1999). T cells activated in MLN circulate to 
intestine as well as other lymphoid tissues including spleen. Previous studies in rats have 
also shown that activated CD4+T cells originating from MLN recirculate to the intestinal 
lymphoid tissues and MLN, where they proliferate; their proliferation on restimulation is 
highest in MLN. The proliferation of CD4+ cells in the MLN was also higher than that of 
CD8+ cells. Whereas MLN contained both naïve T cells (CD45RC high) and 
activated/memory cells (CD45RC low), lamina propria and PP have been shown to contain 
mostly activated T cells. Recent studies in rodents including rat have emphasized the 
importance of dendritic cells (DCs) as exclusive antigen presenters and activators of naïve T 
cells in the draining lymph nodes (Turnbull, E, 2001). Moreover, in the intestine of rat, DCs 
play a prominent role in presenting self tissue antigen, such as derived from apoptotic 
intestinal epithelial cells, to presumably induce tolerance in the lymph node T cells. In rats, 
such tolerogenic DCs appear to be CD4-, while immunogenic DCs are CD4+ cells. 
10. Roles of proliferation and apoptosis in T cell 
homeostasis/dyshomeostasis (Figures 19-20) 
While proliferation and subsequent differentiation of T cells is essential for antigen-specific 
defense against pathogens, T cell apoptosis is an essential cell death process for the 
maintenance of T cell homeostasis. Apoptosis is required also for the deletion of 
overactivated/autoreactive cells and thereby provides for a control of an excessive immune 
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response (Banz, A. 2002).  IL-2 is recognized as a T cell growth factor, but it serves other 
functions as well (Wells, AD, 1999).  T cells, following their interaction with antigen 
presenting cells, produce IL-2, and express high affinity (~10–11 M) IL-2 receptor (IL-2Rαβγ). 
IL-2 acts on the T cells in an autocrine and/or paracrine manner to trigger intracellular 
signaling through JAK/STAT and PI-3K/Ras pathways, and thereby increase cell 
concentrations of cell cycle proteins, cyclin D/E, which in turn associate and activate cyclin-
dependent kinases (Laliberte, J, 1998, Sakaida, H, 1998). These kinases are known to 
phosphorylate proteins responsible for the progression of the cell cycle from G1 to the S 
phase. Thus, IL-2 promotes T cell proliferation. IL-2 also increases production of IFN-γ 
(responsible for stimulation of macrophages) and IL-4 (responsible for developing Th2 
CD4+Tcells, promoting production of antibodies by B cells, and blocking stimulation of 
macrophages) (Jain, J, 1995). IL-2 also modulates T cell apoptosis. T cells (CD4+ and CD8+) 
undergo apoptosis via a “passive” and an “active” mechanism. Active apoptosis of T cells 
occurs after antigen activated T cells, which are producing IL-2 and through IL-2 stimulus 
are proliferating, are restimulated through TCR. Active T cell apoptosis (antigen/activation-
induced cell death, AICD) caused by restimulation restrains T cell expansion due to 
persistent stimulation of T cells (Zheng, L, 1995). Although recent studies support the 
concept that IL-2 is a key regulator of AICD, they have not elucidated mechanism in AICD 
(Boldin, MP, 1995, 1996). Unlike the initial T cell activation which is dependent on TCR and 
costimulatory CD28 receptor activation, AICD is promoted by TCR signal without the 
activation of CD28 (Lenardo, M, 1999). The initial event in AICD is expression on the 
activated T cell surface of FasL/TNF and interactions (in an autocrine or paracrine manner) 
with constitutively expressed Fas receptor (CD95) (and/or TNF-receptor gene superfamily 
members, e.g. TNFR-1 and TNFR-2). Such interactions lead to aggregation of cytoplasmic 
“death domain” of Fas; the components of this complex are: 1) adapter protein, FADD/mort-1, 
and 2) pro-Caspase8 (Zhang, J, 1998). A subsequent step in AICD release of active Caspase 8 
may initiate lethal proteolytic events and activation of caspases including Caspase 3. Caspase 3 
has been considered as a primary initiator of DNA fragmentation (Lenardo, M, 1999). Unlike 
the Fas-FasL mediated apoptosis, TNFR-1 interaction with TNF can signal either apoptosis or 
cell survival. The antiapoptotic process involves activation of NFκB, which transcriptionally 
upregulates anti-apoptotic proteins. Recent studies have indicated also that while Fas 
preferentially controls the death of CD4+ cells, TNFR-1 plays a major role in CD8+T cell death.  
Passive T cell apoptosis presumably occurs after cessation of antigen interaction with T cells 
and of IL-2 production. Passive apoptosis involves activation of the mitochondrial apoptotic 
pathway initiated by a shift in mitochondrial inner membrane permeability causing 
dissipation of mitochondrial membrane potential, δψmw, and release of cytochrome c from 
mitochondria. Cytochrome c complexes with the protein, Apaf-1, and the complex serve to 
activate Caspase 9, which eventually causes activation of Caspase 3 and apoptosis (Clement, 
MV, 1994, Adachi, S. 1997). Under physiological conditions, AICD would be initiated with 
antigen restimulation of T cells, and passive apoptosis involving mitochondrial pathway 
occurs after cessation of IL-2 production. In cases of inadequate activation of AICD, a 
mechanism seems to exist that allows for an amplification of AICD via activation of the 
mitochondrial pathway even in the presence of optimum level of IL-2. It is conceivable that 
in burn/sepsis injury conditions, with suppressed level of IL-2 production by inadequately 
activated T cells, apoptosis might be occurring via both AICD and mitochondrial pathways 
(Luo, X, 1998). Previous studies have supported the concept of AICD potentiation via 
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Fig. 19. The mode of cell death following burn- and sepsis-injury. One cascade of events 
leads to necrosis-mediated inflammation, while another line of events leads to apoptosis. In 
burn and sepsis injury when humoral factors complicated by immune-complex deposition 
and ischemia lead to damaged cell membrane and lysis lead to necrosis and inflammation is 
caused by cell lysate. On the other side TNF/FasL, granzymes and glucocorticoids leading 
to apoptotic changes in the cytoplasm and DNA fragmentation. 
 
 
Fig. 20. A schema of signaling pathways following burn injury-mediated FasL and TNF- 
receptors mediated cell death. Fas and TNF-R1-meditated signaling events lead to 
apoptosis, while TNF-R2 leads to cell survival. 
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mitochondrial path subsequent to an over expression of pro-Caspase 3. Other mechanisms 
of augmentation of apoptosis in T cells with burn/sepsis injury may include that mediated 
by glucocorticoids and/or reactive oxygen species (ROS), both of which are known to be 
generated/released in the burn/sepsis conditions (Fukuzuka, K, 2000, Chao, DT, 1995). The 
glucocorticoids and ROS initiated apoptosis in T cells relies on the mitochondrial pathway 
(Rathmell, JC, 1999). Although apoptosis via various above-discussed mechanisms is 
accompanied by activation of the caspase cascade, there is recent evidence that T cells 
undergo apoptosis independently of the activation of caspases, in vitro. Such caspase-
independent cell death primarily involves the activation of the mitochondrial pathway 
without the involvement of death domain receptors. It is marked, like the caspase-
dependent apoptosis, by the loss of δψmw as well as PS (phosphatidyl serine) translocation 
from inner plasma membrane leaflet to the outer leaflet but, unlike the caspase-dependent 
apoptosis, not marked by DNA fragmentation (Rathmell, JC, 1999).  Cell death regulatory 
proteins of Bcl-2 family play a major role in modulating T cell passive apoptosis. Whereas 
Bcl-2 itself and its homologues, Bcl-xL, Mcl-1 and A1 block apoptosis, others in the family 
such as Bax, Bak, Bad and Bid are known to promote T cell apoptosis. Bcl-2/Bcl-xL inhibit(s) 
release of cytochrome c from mitochondria, prevent (s) cytochrome c binding to Apaf-1 and 
pro-caspase 9, and thereby blocking mitochondrial pathway of apoptosis (Rathmell, JC, 
1999). A possible mechanism by which Bad promotes apoptosis after IL-2 withdrawal could 
be its dephosphorylation and release from its chaperone, in the cytoplasm, followed by its 
binding to Bcl-2 and thus preventing Bcl-2 from blocking apoptosis (Rathmell, JC, 1999). Bcl-
2’s antiapoptotic action could also abrogate if Bax or Bak are highly expressed. Activation of 
Caspase 8 following Fas/FasL interaction can lead to cleavage of cytosolic Bid, and the 
cleaved product has been implicated in the mitochondrial amplification of apoptosis 
(Rathmell, JC, 1999).  
11. Roles of interactions between APCs and T cells through co-stimulatory 
ligands and receptors 
A variety of receptor-ligand interactions take place between APCs (namely, macrophages, 
dendritic cells, B cells) and the T cells after antigen presented by APC is recognized by TCR. 
While some such interactions are ‘adhesive’ and provide for firm cell-cell positioning, others 
transduce cell-cell signals that modulate functional responses by T cells and APCs. APC 
ligands, CD80/86 (B7-1/B7-2), interacting with the CD28 receptor on T cells and causing 
augmentation of TCR-CD3-initiated T cell proliferation and cytokine production, is a classic 
example of a co-stimulatory signal transmission from APC to T cells (Wekerle, T, 2001, 
Zhang, J, 1998).  The importance of CD28 co-stimulation is underscored by the observation 
that in its complete absence, the TCR-mediated cell activation, in vitro, results in T cell 
anergy typified by inadequate IL-2 production and proliferation, and accompanied by 
apoptosis. CD28 signaling appears to be involved in both T cell priming and in generation of 
effector functions in primed T cells; it is, however, critical in T cell priming. Its role in T cell 
differentiation into effector cells is less clear. While CD28 may promote both Th1 and Th2 
responses, it may generate a more exuberant Th2 responses (IL-4 production) than Th1 type 
(IFN-γ production) (Tang Q, 2003). Recent studies have identified a CD28-related molecule, 
ICOS (inducible co-stimulator) as a TCR inducible T cell receptor that binds to APC ligand, 
ICOSL (inducible co-stimulator ligand), a B7 related molecule (B7h) (Lohning, M, 2003,  
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Okazaki, T, 2002, Villegas, EN, 2002). Like CD28/B7-1&2 interactions, ICOS/ICOSL 
upregulate T cell proliferation and cytokine production. Unlike CD28, ICOS signaling may 
be more important in effector cell (Th2 responses) than in CD4+ T cell priming. Unlike CD28 
and ICOS, the T cell receptor, CTLA-4 (cytotoxic T lymphocyte associated protein-4), or the 
recent identified PD-1 (program death-1), both also homologues of CD28, seemingly 
transmit to T cells inhibitory signals that suppress proliferation and cytokine production in 
activated cells (Coyle, AJ, 2001). CTLA-4 also interacts with APC’s CD80/86 molecules. It, 
however, binds to these ligands with greater affinity (~20X greater) than CD28 (Egen, JG, 
2002), which accounts for the abrogation of the co-stimulatory effects of CD28 in the face of 
expression of CTLA-4 on activated T cells. CTLA-4 not only interferes with IL-2 production 
but also causes arrest of T cell cycle in the G1 phase (Alegre ML, 2001).  Unlike CD28, which 
is constitutively expressed and stable, CTLA-4 is induced in activated cells, is relatively 
unstable, and has a much shorter half life (Egen JG, 2002). The CD40 ligand (CD40L), a 
member of TNF family, is expressed on activated T cells; its counterpart CD40, a member of 
TNF-receptor family, is expressed on APCs (Wesa A, 2002). Interactions between T cells’ 
CD40L and B cells’ CD40 are important in humoral immunity (Grammer, AC, 2002). In 
addition, CD40 and CD40L interactions between T cells and other APCs (macrophages, 
DCs) lead to APCs’ upregulation of CD80/86 molecules, and production of IL-12 which is a 
potent cytokine for generation of Th1 type of T cell responses (Coyle AJ,  2001). T cells’ 
response subsequent to CD40L ligation by anti-CD40 was an early/short-term priming of 
TCR followed by cytokine production and proliferation, and a later induction of T cell 
unresponsiveness with upregulation of cytokines, TGF┚ and IL-10, and cell cycle disruption 
(Blair PJ, 2000). The inhibitory effects of CD40L ligation in activated T cells are not clearly 
understood. Several previous studies produced blockade of CD80/86 ligands by treatment 
of experimental animals with a soluble CTLA-4-Ig fusion protein, or of blockade in 
experimental animals of CD40L that prevents CD40 mediated induction of CD80/86 
ligands, have shown a resulting a resulting hyporesponsiveness of T cells allowing for 
acceptance of allotransplanted solid organs by these animals (Honey KS, 1999). Recent 
investigations have indicated that T cell unresponsiveness produced by CTLA-4-Ig 
treatment of animals, receiving solid organ transplantation, may not necessarily be due to 
CD80/86 blockade affecting CD28 co-stimulation but that it could be due to CTLA-4-Ig 
acting as a CTLA-4 mimic that binds and activates CD80/86 molecules on dendritic cells 
(Grohmann U, 2002). Such activation apparently leads to activation of dendritic cell 
intracellular enzyme, indoleamine 2, 3-dioxygenase (IDO), which causes breakdown of 
tryptophan, and accumulation of the breakdown product kynurenine. Since tryptophan is 
required in the microenvironment of the T cells for their proliferation and their possible 
survival, and kynurenine could inhibit T cell proliferation, and promote their apoptosis 
(Grohmann U, 2002, Uyttenhove, C, 2003, Mellor, AL, 2003), the CTLA-4-Ig mediated 
induction of IDO could effectively disturb T cell expansion. This action of CTLA-4-Ig on the 
dendritic cells appears to be mediated by induction of IFNγ, and IFNγ-mediated 
transcriptional upregulation of IDO. IFNγ presumably acted on DCs in an 
autocrine/paracrine manner, and activated STAT-1/NF-κB/p38MAPK signaling pathway. 
As can be surmised from above discussion, studies now support the concept that APC/T 
cell receptor-ligand molecules allow for a bi-directional transmission of signals between 
APCs and T cells; CD80/86/CTLA-4 and CD40L/CD40 appear to be operating in this 
manner. Potential disturbances in CD80/86/CTLA-4 and CD40L/CD40 interactions may 
play role(s) in the T cell hyporesponsiveness in burn/sepsis injury conditions. 
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12. Signaling through receptor systems in T cells 
T cell activation is initiated by triggering TCR with its natural ligand, antigen-MHC 
complex. The proximal signaling events that follow are activations of Src kinases, Lck, Fyn, 
and Lyn, associated with the membrane lipid rafts. Activated Src kinases then 
phosphorylate tyrosine residues in ITAMs (motifs present in the cytoplasmic signaling 
domains of the TCR-CD3 complex) which become the docking sites for the SH2 domains of 
the syk kinase, ZAP-70 (Weiss, A, 1994, Chu D, 1998, Weil R, 1994). ZAP-70 is also 
phosphorylated by the Src kinases. Active ZAP-70 phosphorylate the adapter protein LAT 
present in the lipid rafts. Phosphorylated LAT is able to recruit several other 
phosphorylated key molecules, including enzymes and non-enzyme adapter proteins, to its 
tyrosine-based motifs (Finco, TS, 1998, Zhang W, 1998). Such molecules are: 1) Grb2 
(associated with SOS) which Ras (Downward, J. 1996, Henning, SW, 1998), and 2) SLP-76 
(associated with Gad). SLP-76 recruits a Tec kinase which activates PLCγ. PLCγ 
enzymatically cleaves membrane inositol-4, 5 bisphosphate leading to formation of inositol-
1, 4, 5 triphosphate (IP-3) and diacylglycerol (DAG) (Berridge, MJ, 1998). Ras couples to 
distal effector signaling pathways including the activation of MAPKs (Erk, JNK, and p38 
MAPK). Erk plays an essential role in the activation of transcription factors, c-Fos and c-
myc; c-Fos is involved in the transcriptional regulation of activated protein-1 (AP-1) 
response element in the IL-2 promoter (Gupta, S, 1994, Rincon, M, 2000). JNK is also 
involved in the activation of IL-2 promoter but a lesser extent than Erk (Su B, 1994). p38 
MAPK is involved in the activation of IFNγ gene expression, as well as playing a role in the 
induction of T cell apoptosis  (Gupta, S, 1994). IP-3, generated after the action of PLCγ, 
causes release of Ca2+ from endoplasmic reticulum storage site. Once the stored Ca2+ is 
depleted from the endoplasmic reticulum, depletion triggers extracellular Ca2+ influx 
through a plasma membrane capacitative Ca2+ entry channel (Berridge, MJ, 1998), sustaining  
high Ca2+ concentration required for IL-2 promoter activation by calcineurin, a Ca2+-
calmodulin dependent serine phosphatase. Calcineurin dephosphorylates NFAT which 
translocates to the nucleus and binds in the IL-2 promoter region (Baksh, S., 2000, 
Penninger, JM, 1999). DAG activates certain isoforms of PKC,  also dependent on Ca2+ , 
namely,  PKC and certain novel isoforms, PKCδ, ε, ν, and θ, that are not dependent on Ca2+  
(Mellor H, 1998). In T cells, PKCθ is the only isoform that is recruited to the membrane and 
is involved in the activation of NFκB (Monks CR, 1997).  Src and Syk kinases are thus 
involved in the activation of distal pathways: 1) Grb2/p21ras/MAPKs, 2) 
PLCγ/Ca2+/calcineurin, and 3) DAG/PKCθ/NFκB pathways; Src/Syk tyrosine kinases 
additionally activate phosphatidylinositol 3-kinase (PI-3K) which leads activation of a 4th 
Vav/Rac-1/PKCθ/Akt/NFκB pathway. PI-3K is recruited through its regulatory SH-2 
domain to LAT, and phosphorylates the D-3 position of inositol phosphate (IP) in the 
membrane. Phosphorylated IPs interact with PH domains of PLCγ, Tec kinase, Vav in the 
lipid rafts (Viola A, 1999). Vav is a GEF for Rac-1, which activates JNK and cytoskeletal 
assembly; Vav also recruits PKCθ  (Herndon, TM, 2001). PI-3K also activates serine-
threonine kinase, Akt (PKB) (Ward, SG, 1996, Bruyns, E, 1998).  Both Akt and PKCθ activate 
NFκB (Alessi, DR, 1998). Nascent NFκB/Rel family proteins, present as dimers, are held in 
the cytoplasm by IκB. Degradation of IκB by proteasome (dependent on ubiquitination) 
occurs phosphorylation of IκB by IκB kinase complex (IKK) (DiDonato, JA, 1997, Regnier, 
CH. 1997), and allows for liberation of NFκB dimmers allows which them translocate to the 
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nucleus, and bind DNA to transcriptionally upregulate various genes. Co-stimulatory 
receptor CD28’s cytoplasmic tail PR motifs are also involved in the recruitment and 
activation of Srk kinases, Fyn and Lck, and Tec kinases leading to acticvation of PI-3K, Grb2, 
and JNK (Su B, 1994, Harhaj, EW, 1998). Although several studies have attempted to 
evaluate the roles of PI-3K and Grb2 after CD28 costimulation on IL-2 production and 
proliferation, no definitive information has yet come forth from them (Chan, TO, 1999, 
Parry, RV, 1997). However, PI-3K activation with co-stimulation has been implicated in the 
activation of Akt followed by that of NFκB resulting in an upregulation of the anti-apoptotic 
protein Bcl-xL (Chao, DT, 1995, Boise, LH, 1995). Akt regulation with CD28 costimulation 
has been shown to possibly induce IL-2 and IFN┛ production without affecting IL-4 and IL-5 
but remains questionable. Thus, although CD28 costimulation is known to prevent T cell 
anergy through its effect on IL-2 production and cell cycle progression, the signaling 
mechanisms of this effect have remained elusive. CD28 stimulation probably exerts its effect 
on IL-2 mRNA upregulation and proliferation by enhancing tyrosine phosphorylation of 
TCR, and by decreasing threshold for naïve T cell activation through the assembly of 
signaling components in the “immunological synapse” housing the TCR/CD3-MHC-
peptide/CD28/CD80, 86/SrcKs/PKCθ molecular complex at the T cell and APC interface.  
Like CD28, CTLA-4 contains in its cytoplasmic tail tyrosine and PR regions. An 
unphosphorylated tyrosine residue allows for an association between CTLA-4 cytoplasmic 
domain and the AP50 (medium chain subunit of the clathrin adapter, AP-2) resulting in 
clathrin-dependent endocytosis of CTLA-4, and thus control over its cell surface retention. 
After TCR stimulation, the cytoplasmic tyrosine(s) are phosphorylated by Src kinases 
Lck/Fyn that promotes CTLA-4’s surface retention. Crosslinking of CTLA-4 reduces TCR-
dependent activation of MAPKs, Erk and JNK, as well as of NFκB, NFAT, and AP-1. 
Ligation of CTLA-4 during TCR stimulation results in decreased T cell cytokine production 
and arrest of the cell cycle (Coyle AJ, 2001, Sharpe, AH, 2002). Although an association of 
SH-2 motif containing tyrosine phosphatase (SHP-2) with CTLA-4’s cytoplasmic tyrosine 
residue is not established, an indirect association of CTLA-4 with SHP-2 might result in 
dephosphorylation of the CD3 complex and inactivation of TCR signaling mechanism 
(Walunas, TL, 1996, Marengere, LE, 1996). The available research reports of T cell signaling 
pathways provide a more extensive characterization of TCR-related signaling than that 
triggered by co-stimulatory or inhibitory T cell/APC surface molecules. However, it is clear 
there are redundancies in the pathways activated by the TCR-related and co-stimulatory 
signals. 
13. Conclusion (Figure 21-23) 
Attempts to clinically improve immunosuppression following burn and/or sepsis has been 
largely unsuccessful. Immune dysfunction that normally occurs in such a massive burn 
injury condition affects both innate and adaptive immune responses, including humoral and 
especially cell-mediated responses. T-cell or antigen-presenting cell malfunctions occur late. 
Infection, sepsis, and multiple organ failure take weeks to months to evolve following burn 
injury. Most of the experimental animal models of burn injury target early adaptive immune 
response and fail to give the true picture of ensuing immunosuppression. Effective therapy 
requiring modifying signaling pathways distal to CD3 ligation have been proposed by some 
while others propose nuclear factor-ΚB and downstream mediators as potential targets for 
treating burn-induced immunosuppression. 
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Fig. 21. A summary of events where both inname and adaptive immune response 
orchestrate complex interaction of cells and their released products to mount a competent 
immune defense. 
 
 
Fig. 22. A flow diagram of possible cellular and humoral factor interactions that occurs in a 
dysregulated immune response in sepsis. 
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Fig. 23. A list of potential causes accounting for a failed immunotherapy against clinical sepsis. 
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